Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Aldehyde Oxidase 1 (AOX1) in Human Liver Cytosols: Quantitative Characterization of AOX1 Expression Level and Activity Relationship

Cexiong Fu, Li Di, Xiaogang Han, Cathy Soderstrom, Mark Snyder, Matthew D. Troutman, R. Scott Obach and Hui Zhang
Drug Metabolism and Disposition October 2013, 41 (10) 1797-1804; DOI: https://doi.org/10.1124/dmd.113.053082
Cexiong Fu
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Di
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaogang Han
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cathy Soderstrom
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Snyder
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D. Troutman
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhang
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 41 no. 10 1797-1804
DOI 
https://doi.org/10.1124/dmd.113.053082
PubMed 
23857892

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 31, 2013
  • Accepted July 15, 2013
  • Published online September 16, 2013.

Article Versions

  • Earlier version (July 15, 2013 - 08:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Cexiong Fu,
  2. Li Di,
  3. Xiaogang Han,
  4. Cathy Soderstrom,
  5. Mark Snyder,
  6. Matthew D. Troutman,
  7. R. Scott Obach, and
  8. Hui Zhang
  1. Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut (C.F., L.D., X.H., C.S., M.D.T., R.S.O., H.Z.); and Scienion US, Inc., Monmouth Junction, New Jersey (M.S.)
  1. Address correspondence to:
    Dr. Hui Zhang, Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Pfizer, Inc., Mailstop 8220-2155, Groton, CT 06340. E-mail: hui.zhang3{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2013 to May 2022

AbstractFullPdf
Jul 20135114127
Aug 2013207055
Sep 201380917114
Oct 20137193090
Nov 20134451154
Dec 20131051231
Jan 2014731227
Feb 201467925
Mar 2014731022
Apr 2014521224
May 201432530
Jun 201446723
Jul 201435211
Aug 2014471026
Sep 201433824
Oct 2014392324
Nov 2014342932
Dec 2014692122
Jan 2015413534
Feb 2015132425
Mar 2015192917
Apr 2015331214
May 2015212223
Jun 201526918
Jul 2015311520
Aug 2015252521
Sep 2015413932
Oct 2015282031
Nov 2015431711
Dec 201534921
Jan 2016241619
Feb 2016251520
Mar 2016211124
Apr 2016231316
May 201620716
Jun 2016262123
Jul 2016391826
Aug 2016291737
Sep 2016382334
Oct 2016173719
Nov 2016135933
Dec 201684125
Jan 201713415
Feb 201733918
Mar 201725712
Apr 20174329
May 201782825
Jun 201774219
Jul 2017112712
Aug 201773221
Sep 201759427
Oct 2017310731
Nov 201763333
Dec 201703319
Jan 201864420
Feb 201874018
Mar 201855933
Apr 201824619
May 201825817
Jun 201835735
Jul 20181318
Aug 201803516
Sep 201813819
Oct 201803413
Nov 201832337
Dec 2018261213
Jan 201916212
Feb 2019716
Mar 201937213
Apr 201949424
May 201912810
Jun 201913710
Jul 201920515
Aug 201925610
Sep 201937411
Oct 20192524
Nov 201938820
Dec 201943916
Jan 20203435
Feb 20204114
Mar 20202869
Apr 20202699
May 20201543
Jun 20202222
Jul 20202135
Aug 20201721
Sep 20203954
Oct 20203467
Nov 20201154
Dec 20202727
Jan 202122217
Feb 2021291715
Mar 20213256
Apr 2021321014
May 20214044
Jun 20213693
Jul 20213067
Aug 2021401211
Sep 202132812
Oct 20214735
Nov 20215846
Dec 20215537
Jan 20221273
Feb 202249713
Mar 20221933
Apr 20223073
May 20221113

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 41 (10)
Drug Metabolism and Disposition
Vol. 41, Issue 10
1 Oct 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aldehyde Oxidase 1 (AOX1) in Human Liver Cytosols: Quantitative Characterization of AOX1 Expression Level and Activity Relationship
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

AOX1 Expression Level and Activity Relationship

Cexiong Fu, Li Di, Xiaogang Han, Cathy Soderstrom, Mark Snyder, Matthew D. Troutman, R. Scott Obach and Hui Zhang
Drug Metabolism and Disposition October 1, 2013, 41 (10) 1797-1804; DOI: https://doi.org/10.1124/dmd.113.053082

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

AOX1 Expression Level and Activity Relationship

Cexiong Fu, Li Di, Xiaogang Han, Cathy Soderstrom, Mark Snyder, Matthew D. Troutman, R. Scott Obach and Hui Zhang
Drug Metabolism and Disposition October 1, 2013, 41 (10) 1797-1804; DOI: https://doi.org/10.1124/dmd.113.053082
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics